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Abstract
Background: A subgroup of patients suffering from Lyme disease (LD) may initially respond
to antibiotics only to later develop a syndrome of fatigue, joint pain and cognitive dysfunction
referred to as ‘post treatment LD syndrome’. We report on a series of patients who developed
autonomic dysfunction in the form of postural orthostatic tachycardia syndrome (POTS).
Methods: All of the patients in this report had suffered from LD in the past and were successfully
treated with antibiotics. All patients were apparently well, until years later when they presented
with fatigue, cognitive dysfunction and orthostatic intolerance. These patients were diagnosed
with POTS on the basis of clinical features and results of the tilt table (HUTT) testing.
Results: Five patients (all women), aged 22–44 years, were identified for inclusion in this
study. These patients developed symptoms of fatigue, cognitive dysfunction, orthostatic palpita-
tions and either near syncope or frank syncope. The debilitating nature of these symptoms had
resulted in lost of the employment or inability to attend school. Three patients were also
suffering from migraine, two from anxiety and depression and one from hypertension. All
patients demonstrated a good response to the employed treatment. Four of the five were able to
engage in their activities of daily living and either resumed employment or returned to school.
Conclusions: In an appropriate clinical setting, evaluation for POTS in patients suffering
from post LD syndrome may lead to early recognition and treatment, with subsequent improve-
ment in symptoms of orthostatic intolerance. (Cardiol J 2011; 18, 1: 63–66)
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Introduction
Lyme disease (LD), a tick-borne illness caused
by the spirochete borellia burgdorferi, is the multi-
-system disorder that begins with erythema migrans
and may later be followed by widespread complica-
tions which may involve the nervous system, cardio-
vascular system and musculoskeletal system [1, 2].
While most of these manifestations usually respond
to antibiotic treatment, there is a subgroup of pa-
tients who later develop a syndrome of fatigue, joint
pains and cognitive dysfunction known as ‘post treat-
ment LD syndrome’ [3–5]. The post treatment LD
syndrome has been reported to result in a substan-
tial decline in the quality of life in affected patients
[5]. We present a series of patients who suffered from
LD and were successfully treated initially with anti-
biotics, but who later developed a syndrome of fa-
tigue, cognitive dysfunction and symptoms of ortho-
static intolerance (OI). Further investigation re-
vealed that each of these patients was suffering from
postural orthostatic tachycardia syndrome (POTS).
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Methods
This was a single center report on a series of
five patients who followed our clinic for orthostatic
intolerance. This study was approved by our local
Institutional Review Board. All of these patients had
suffered from LD in the past and were successfully
treated with antibiotics. All of these patients were
apparently well, until years later when they started
with fatigue, cognitive dysfunction and OI. In
a retrospective chart review, we collected data in-
cluding demographic information, presenting symp-
toms, laboratory data, tilt-table response, and treat-
ment outcomes. OI refers to a heterogeneous group
of disorders of hemodynamic regulation character-
ized by insufficient cerebral perfusion resulting in
symptoms during upright posture relieved by recum-
bency. Symptoms included syncope, near syncope,
fatigue, palpitations, exercise intolerance, lighthead-
edness, diminished concentration, and headache [6].
Head up tilt test (HUTT) protocol
The protocol used for tilt table testing has been
described elsewhere, but basically consisted of a 70-
-degree baseline upright tilt for a period of 30 min,
during which time heart rate and blood pressure
were monitored continually [7]. If symptomatic
hypotension and bradycardia occurred, reproducing
the patient’s symptoms, the test was ended. If no
symptoms occurred, the patient was lowered to the
supine position and an intravenous infusion of iso-
proterenol started with a dose sufficient to raise the
heart rate to 20–25% above the resting value. Up-
right tilt was then repeated for a period of 15 min.
Criterion for diagnosing postural
orthostatic tachycardia syndrome
POTS was defined as symptoms of OI (of
greater than six months’ duration) accompanied by
a heart rate increase of at least 30 bpm (or a rate that
exceeds 120 bpm) observed in the first ten minutes
of upright posture or HUTT occurring in the absence
of other chronic debilitating disorders [6, 7].
Treatment protocols
The treatment protocols employed were based
on our previous experiences with orthostatic dis-
orders and are described in detail elsewhere [6–11].
Briefly, a sequence of therapies is employed that
included physical counter maneuvers as well as in-
creased dietary fluids and sodium. If these were
ineffective, pharmacotherapy was initiated in a se-
quence generally consisting of fludrocortisone, mi-
dodrine, methylphenidate, selective serotonin re-
uptake inhibitors, pyridostigmine, and erythropoi-
etin, either alone or in combination. The rationale
for this sequence and the doses employed are de-
scribed in detail elsewhere. A treatment was con-
sidered successful if it provided symptomatic relief.
Not all drugs were used in every patient.
Results
Five patients (all women), aged 22–44 years,
were identified for inclusion in this study. All these
patients had suffered from LD and were apparently
cured with antibiotics and were asymptomatic for
periods ranging from two to 12 years. Table 1 sum-
marizes the clinical features of these patients.
Diagnosis of Lyme disease
LD was diagnosed in each patient based on the
combined clinical criteria and immunological respons-
es seen against borrelia burgdorferi. Each patient had
an acute episode of LD. None presented with any car-
diac complications. The acute episode presented mainly
as skin rash with a prior history of tick bite. All these
patients had suffered from LD and were apparently
cured with antibiotics and were asymptomatic for pe-
riods ranging from two to 12 years (Table 1).
Symptoms of orthostatic intolerance
After the quiescent period of two to 12 years
following their initial infection with LD, all these
patients developed symptoms of fatigue, cognitive
dysfunction, orthostatic palpitations and either near
syncope or frank syncope. These symptoms had
resulted in substantial limitation of activities of daily
living, to such an extent that each patient either lost
their employment or became unable to attend
school. The fear of passing out upon standing had
resulted in substantial limitation and all these pa-
tients had initially become housebound.
Tilt testing
All five patients were evaluated by a head up tilt
table testing. All demonstrated a tilt pattern consis-
tent with POTS (the criteria have been discussed in
the methods section above). Three patients had a tilt
table response seen within the ten minutes; the other
two patients had to be started on an isoproterenol
infusion before the test was repeated.
Comorbidity
Three patients complained of recurrent mi-
graines, two of anxiety and depression, and one of
hypertension. The patient who was suffering from
hypertension had wide fluctuations in her blood
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pressure, with episodes of very high blood pressure
followed by episodes of hypotension.
Medications
The commonly used medications in this group
of patients were fludrocortisone (in two) and pyri-
dostigmine (in three). Bupropion, erythropoietin and
clonidine were used in one patient each (Table 2).
Response to treatment
All patients demonstrated a good response to
the employed treatment. The orthostatic symptoms
(especially fatigue) improved in all of them. In three
patients, their syncope was completely abolished,
while two patients have continued to have syncope
but at a much lesser frequency than before starting
treatment. All except one patient were able to en-
gage in their daily activities and either resume em-
ployment or return to school.
Discussion
A subgroup of patients diagnosed with chronic
LD may in fact have post LD syndrome. These pa-
tients usually improve initially with the antibiotics
and have resolution of physical symptoms and signs
of LD. However, after a quiescent period, they again
develop symptoms of fatigue, pain and cognitive
dysfunction. Interestingly, these symptoms usual-
ly develop within six months following a success-
ful treatment with antibiotics. The exact etiology
of this syndrome remains elusive. Randomized tri-
als have failed to show any benefit of continued
antibiotic use in patients suffering from post LD
syndrome, as this syndrome is not thought to be due
to persistence of spirochete infection in this group
of patients [13–15]. In a recent report by Chandra
et al. [16] anti-neural antibody reactivity was found
to be significantly higher in the patients suffering
from post LD syndrome (49%) as compared to post
Lyme healthy individuals (18.5%) or healthy indi-
viduals without a history of LD (15%) with a p <
< 0.01. It has been postulated that LD can trigger
‘auto antibodies’ that can bind or block post-synaptic
acetylcholine receptors in the autonomic ganglia.
However, due to the retrospective nature of the cur-
rent study, we did not check for synaptic antibodies.
All our patients demonstrated a good response
to pyridostigmine. Pyridostigmine augments the
availability of acetylcholine at the synaptic cleft by
inhibiting acetylcholine esterase, an enzyme that
causes hydrolysis of acetylcholine. Pyridostigmine
has been shown to improve symptoms in patients
suffering from POTS or OI [17, 18]. Clinical symp-
toms of post LD syndrome are debilitating and have
been reported to impair quality of life [5]. In our
patients, symptoms of fatigue, orthostatic palpita-
tions, cognitive dysfunction and syncope had result-
ed in substantial impairment of the quality of life in
each patient. After diagnosis and initiation of the
treatment, all but one patient reported a marked
Table 1. Clinical characteristics of the postural orthostatic tachycardia syndrome patients with
pre-existing post Lyme disease syndrome.
Patient # 1 2 3 4 5
Age (years) 44 33 31 23 21
Onset after Lyme disease (years) 3 12 5 4 4
Fatigue + + + + +
Orthostatic palpitations + + + + +
Near syncope + + + + +
Syncope + + + + +
Cognitive dysfunction + + + + +
Anxiety + – – + –
Depression + + – – –
Migraine + – + – +
Hypertension – + – – –
Table 2. Various treatments employed in the stu-
dy group.
Fludrocortisone + – – + –
Pyridostigmine – + + + +
Bupropion + – – – –
Clonidine – + – – –
Erythropoietin – – + – –
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improvement in their symptoms and quality of life.
While there is no proven therapy for symptom con-
trol in patients suffering from post-treatment LD
syndrome, it is possible that some of these patients
might have OI as a contributor to their symptoms.
Recognition of orthostatic intolerance in this subset
of patients may lead to the initiation of appropriate
treatment earlier, with subsequent improvement in
their symptoms and quality of life. Physicians need
to have a high index of suspicion for OI in patients
suffering from post-treatment LD syndrome.
Limitations of the study
This was a retrospective report on a relatively
small number of patients. Because of the retrospec-
tive nature and small number we could not estimate
any incidence of POTS in patients suffering from
post LD syndrome. Also, some questions such as
why only a few patients with post LD develop POTS
remain unanswered from this report. A high index
of suspicion for POTS may allow for its early rec-
ognition and treatment in patients suffering from
post LD syndrome.
Conclusions
In an appropriate clinical setting, evaluation for
POTS in patients suffering from post LD syndrome
may lead to earlier recognition and treatment, with
subsequent improvement in symptoms of OI.
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